Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLS | O94925 | 1/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.31 |
| ▸ | ITGAV | P06756 | 1/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.31 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1005092 | 1.00 | GLS (0.47) | GLSAPEX1KDM4ETSHRHTT | |
| SCHEMBL473047 | 1.00 | GLS (0.47) | GLSAPEX1KDM4ETSHRHTT | |
| Biphenyl SCHEMBL7177377 | 0.89 | GLS (0.41) | GLSAPEX1KDM4ETSHRHTT | |
| SCHEMBL9460988 | 0.86 | GLS (0.46) | GLS | |
| SCHEMBL18218788 | 0.85 | GLS (0.47) | GLSHTTSMN1; SMN2BACE1 | |
| SCHEMBL18914987 | 0.85 | GLS (0.47) | GLSKDM4EBACE1 | |
| SCHEMBL18219056 | 0.85 | GLS (0.47) | GLSHTTSMN1; SMN2BACE1 | |
| SCHEMBL23296774 | 0.83 | GLS (0.46) | GLSBACE1 | |
| SCHEMBL183678 | 0.83 | GLS (0.46) | GLSBACE1 | |
| SCHEMBL2280018 | 0.83 | GLS (0.46) | GLSBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118948698-B | Refreshing oil control composition and preparation process thereof | 广州市可颜化妆品有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-118948698-A | Refreshing oil control composition and preparation process thereof | 广州市可颜化妆品有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-102617540-A | Method for preparing (S)-3,6-dioxo-5,6-isopropylidene-5,6-dyhydroxyl hexanoic acid tert-butyl ester | JIANGSU SHIMEIKANG PHARMACEUTICAL CO LTD | 2012-08-01 | — | — | CN | claimed |
| CN-101029034-A | Polyenic taxol soluble derivative, its preparation and use | UNIV ZHEJIANG (CN) | 2007-09-05 | — | — | CN | claimed |
| US-12617782-B2 | Pyridazinones as PARP7 inhibitors | RIBON THERAPEUTICS, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260116913-A1 | NEUROSTEROID COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS | TEXAS A & M UNIV SYS (US) | 2026-04-30 | — | — | US | disclosed |
| US-12509487-B2 | Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2025-12-30 | — | — | US | disclosed |
| EP-4594319-A1 | BICYCLIC COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025134071-A1 | MALIC AND GLUTARIC ACID BASED IONIZABLE LIPIDS | SANOFI (FR) | 2025-06-26 | — | — | WO | disclosed |
| CN-118948698-B | Refreshing oil control composition and preparation process thereof | 广州市可颜化妆品有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-118948698-A | Refreshing oil control composition and preparation process thereof | 广州市可颜化妆品有限公司 | 2024-11-15 | — | — | CN | disclosed |
| US-12037354-B2 | Cyclic pantetheine derivatives and uses thereof | VECTIVBIO COMET AG (CH) | 2024-07-16 | — | — | US | disclosed |
| US-5606101-A | INTERMEDIATES FOR SQUALENE SYNTHASE INHIBITORS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-02-25 | — | — | US | disclosed |
| EP-0464817-B1 | 2,4-Dihydroxyadipic acid derivative | KANEGAFUCHI CHEMICAL IND (JP) | 1996-10-09 | — | — | EP | disclosed |
| US-5504107-A | ANTICOAGULANTS, PREVENTING ATHEROSCLEROSIS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1996-04-02 | — | — | US | disclosed |
| US-5488149-A | SQUALENE SYNTHASE INHIBITORS AS ANTICHOLESTEROL OR ANTILIPEMIC AGENTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1996-01-30 | — | — | US | disclosed |
| WO-1995032194-A1 | SYNTHESIS OF OPTICALLY PURE 4-ALKENYL- OR 4-ALKANYL-2-HYDROXYTETRONIC ACIDS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1995-11-30 | — | — | WO | disclosed |
| EP-0611749-A1 | Substituted amic acid derivatives useful for treatment of arteriosclerosis | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1994-08-24 | — | — | EP | disclosed |
| US-5214197-A | 2,4-DIHYDROXYADIPIC ACID DERIVATIVE | KANEGAFUCHI CHEMICAL INDUSTRY CO., LTD. (JP) | 1993-05-25 | — | — | US | disclosed |
| EP-0464817-A1 | 2,4-Dihydroxyadipic acid derivative | Kanegafuchi Chemical Industry Co., Ltd. (JP) | 1992-01-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509487-B2 | Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders | SLC6A11, GABRE, SLC6A13 | GLS 1422/4885APEX1 4847/4885KDM4E 2859/4885 |
| US-12617782-B2 | Pyridazinones as PARP7 inhibitors | PARP3, PARP2, PARP1 | GLS 135/4885APEX1 456/4885KDM4E 2722/4885 |
| US-12037354-B2 | Cyclic pantetheine derivatives and uses thereof | VNN1, VKORC1, PANK3 | GLS 727/4885APEX1 2207/4885KDM4E 4437/4885 |
| US-20260116913-A1 | NEUROSTEROID COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS | CHRNA9, HSD3B2, HSD3B1 | GLS 2814/4885APEX1 3944/4885KDM4E 2002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.